creation date: 2025-09-25 16:30
tags: Pathologies
Hypokalemia
Background
Definitions
Hypokalemia refers to a serum potassium level below normal limits. This is one of the most common electrolyte disturbances.
Etiology
A number of causes can result in hypokalemia. Broadly, they are categorized:
Decreased sodium intake (rarely results in hypokalemia alone)
- Poor nutrition or dietary restriction
- Eating disorders
Increased intracellular uptake
- Insulin injection
- Beta-adrenergic inhalation
Increased potassium losses
- Excessive sweating
- Loop diuretic intake (inhibits Na-K-Cl cotransporters which reduces reuptake in loop of Henle)
- Medications that increase distal sodium delivery
- Distal Na reabsorption trades potassium into tubule
- Increased sodium reabsorption results in lower cation concentration which increases potassium secretion (eg. thiazide diuretics)
- Renal disorders which includes:
- Chloride-responsive metabolic alkalosis (eg. chloride depletion from vomiting)
- Chloride-resistant metabolic alkalosis (eg. due to mineralocorticoid excess)
- Renal tubular acidosis
- Genetic conditions
- Diarrhea/vomiting
- NG tube suctioning
Pathogenesis
Potassium is integral to many physiological processes within the body and disruption to its levels result in the myriad of symptoms which present.
Briefly, potassium is involved in maintaining cell membrane potentials, nerve impulse conduction, muscle functions, and acid-base balance.
Hypokalemia can lead to impairment of neuromuscular transmission and thus muscle contraction, affecting skeletal, smooth, and cardiac muscles. Severe forms of this presents as paralysis. Potassium also mediates vasodilation for muscle blood flow and depletion can result in ischemia and subsequent muscle injury.
Additionally, disruptions in cardiac electrical activities may occur. Cardiac membrane potentials can shift and repolarization delayed. This can increase the risk of cardiac arrhythmias and arrest/sudden death.
Prolonged hypokalemia can cause damage to the kidney and decrease the body’s sensitivity to insulin possibly contributing to type 2 diabetes.
Clinical Presentation
Signs & Symptoms
The manifestations of hypokalemia are typically proportional to the degree and duration of reduction of serum potassium. Symptoms typically manifest when serum potassium is below 3.0 mmol/L.
Muscle weakness
- Typically occurs when serum potassium <2.5 mmol/L
- Begins in the lower extremities and progresses caudally
- Can worsen to point of paralysis
- May manifest with muscle cramps, rhabdomyolysis, and myoglobinuria
- Respiratory failure
- Gastrointestinal symptoms due to decreased gut motility
Cardiac arrhythmias and ECG abnormalities
A number of arrhythmia may present:
- Premature atrial complexes
- Premature ventricular complexes
- Sinus bradycardia
- Paroxysmal atrial or junctional tachycardia
- AV block
- Atrial fibrillation
- Ventricular tachycardia/fibrillation (particularly increased in risk during STEMI)
Hypokalemia also has characteristic ECG findings:
- ST depression
- T-wave amplitude decrease
- U-wave amplitude increase (second peak after T) - particularly in V4-V6
- QT-interval increase
Kidney abnormalities
Prolonged hypokalemia can reduce renal function which can result in:
- Electrolyte imbalances
- Impaired urine concentration
- Elevated blood pressure
History & Physical Exam
History should aim to identify the cause of hypokalemia. This may be apparent such as with reports of vomiting, diarrhea, or diuretic therapy.
Physical exam should evaluate for functional manifestations such as muscle weakness.
Diagnosis
Criteria
The lower limit of normal serum potassium is 3.5 mmol/L.
Severity is sometimes classified using:
- Mild: 3.0-3.4 mmol/L
- Moderate: 2.5-3.0 mmol/L
- Severe: <2.5 mmol/L (emergent)
Work-up
In many cases, the etiology of hypokalemia is clear from history. However, further investigations can assess for severity and guide treatment of complications. This typically includes:
- Serum electrolytes (and creatinine/eGFR)
- Serum magnesium if suspected
- Electrocardiogram
In some cases, renal ultrasound may be considered for evaluation of kidney abnormalities. Chest radiograph may be useful for revealing lung pathologies that contribute to alkalosis.
In severe hypokalemia, a venous blood gas is often used (rarely ABG) for acid-base status.
Differential
The differential consist primarily of underlying conditions that results in hypokalemia.
Red Flags / Complications
In the most severe form, hypokalemia can result in:
- Cardiac failure
- Respiratory failure
- Paralysis
Management
The goal of treatment is to:
- Prevent/treat life-threatening complications
- Replace potassium
- Correct underlying cause
The mainstay treatment of hypokalemia is potassium replacement. Potassium replacement can be administered as:
- Potassium chloride (eg. Slow-K+)
- Fastest replacement, may aggravate metabolic alkalosis
- Available as salt substitute, liquid, slow-release tablet/capsule, IV
- Potassium phosphate
- Rarely used, for hypokalemic hypophosphatemic patients
- Potassium bicarbonate (or precursors: potassium citrate, potassium acetate IV)
- Preferred for hypokalemia with metabolic acidosis
- Potassium gluconate
In severe or symptomatic hypokalemia or patients unable to take potassium orally, adjunctive IV potassium repletion can be considered. Infusion should be done with a non-dextrose fluid (eg. saline) to prevent intracellular potassium uptake.
In cases where hypokalemia cannot be corrected with supplementation alone, a potassium-sparing diuretic can be used, albeit with an increased risk of hyperkalemia:
- Amiloride or triamterene (cortical collecting tubule sodium channel blockers)
- Spironolactone or eplerenone (aldosterone antagonist)
It should be noted that absorption of potassium intracellularly is slow and thus transient hyperkalemia is a complication to be avoided. Close monitoring of serum potassium is necessary during repletion.
In cases of hypomagnesemia, it should be corrected concurrently. Similarly, if etiology relates to increased sympathetic tone (eg. hypokalemia thyrotoxic paralysis), a nonspecific beta blocker should be considered.
In patients with diabetic ketoacidosis or HHS, potassium moves out of cells and thus can result in an elevated serum potassium and/or result in severe total potassium deficit (intracellular potassium is shifted out). Treatment should proceed with care due to risk of severe hypokalemia when insulin is administered.
In cases where potassium loss in anticipated (eg. patient is on a diuretic), a maintenance dose of slow-K+ may be indicated.